AXON reported Q4 earnings after the close Tuesday. Shares are up 16% after hours in response to the impressive results. With robust revenue growth and incremental margin improvements, AXON is shaping up to be a winner.
The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Axon Enterprise (AXON) came out with quarterly earnings of $2.15 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $2.08 per share a year ago.
Axon Enterprise (AXON) stock has dropped by 29.2% in under a month, from $613.14 on January 23, 2026, to $433.91 currently. What's next?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Axon Enterprise (AXON) concluded the recent trading session at $441.12, signifying a +2.56% move from its prior day's close.
Beyond analysts' top-and-bottom-line estimates for Axon (AXON), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.
Zacks.com users have recently been watching Axon (AXON) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
We invest in secular growth and innovative businesses across all market capitalizations, with the bulk of the portfolio landing in the large-cap zone. We recently initiated a position in Axon Enterprise. We exited our successful investment in Exact Sciences Corporation after Abbott Laboratories announced it was acquiring the company for approximately $23 billion in cash.
The latest trading day saw Axon Enterprise (AXON) settling at $434.45, representing a -2.8% change from its previous close.
Axon (AXON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?